NCT05581641 - Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

February 23, 2024

Study Completion Date

September 6, 2024

Conditions

Malaria

Interventions

BIOLOGICAL

BNT165b1

RNA vaccine for active immunization against malaria administered as intramuscular injection.

OTHER

Placebo

Placebo matched to RNA vaccine administered as intramuscular injection.

Trial Locations (5)

University of Maryland, Center for Vaccine Development, Baltimore

Alliance for Multispecialty Research, LLC, Knoxville

Clinical Trials of Texas, Inc., San Antonio

Alliance for Multispecialty Research, LLC, Tempe

Alliance for Multispecialty Research, LLC, Las Vegas